Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Invanz I.V. or I.M. (Ertapenem Sodium)
Company:  Merck & Co., Inc.
Application No.:  21-337
Approval Date: 11/21/01


Date created: November 20, 2001

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.